US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Fate Therapeutics Inc (FATE)
Fate Therapeutics Inc (FATE) ニュース

FATE

Fate Therapeutics (FATE)

Fate Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FATE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/10	05 : 01	GlobeNewswire Inc.	Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/09	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/09	21 : 30	GlobeNewswire Inc.	Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/04	05 : 30	GlobeNewswire Inc.	Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/23	05 : 30	GlobeNewswire Inc.	Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/03	21 : 00	GlobeNewswire Inc.	Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/03	05 : 01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/19	21 : 44	GlobeNewswire Inc.	Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/06	06 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/06	06 : 01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/05	03 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/01	22 : 00	GlobeNewswire Inc.	Fate Therapeutics to Present at Upcoming March Investor Conferences	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06 : 10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06 : 01	GlobeNewswire Inc.	Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/15	22 : 00	GlobeNewswire Inc.	Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/13	08 : 06	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06 : 01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/31	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/30	03 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/26	06 : 19	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:FATE

1 2 3 4 5 6 7 8 9 10 次へ >>

Vontobel Financial Produ...

Jpmorgan Chase Financial...

Origen Resources

Franklin Growth & Income...

WisdomTree Commodity Sec...

ELETS280 Ex:27,6

NVIDIA Corp DRN

Innovative Technology Po...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約